Novartis Announces $771 Million Manufacturing Expansion in North Carolina, Creating 700 Jobs
Key Insights
Novartis is expanding its pharmaceutical manufacturing operations in Durham and Wake counties with a $771 million investment by 2030.
The Swiss drugmaker plans to create 700 new jobs across three sites, combining new construction with renovation of existing facilities.
New positions will offer an average annual salary of $111,161, exceeding local county averages in both Durham and Wake counties.
Swiss pharmaceutical giant Novartis has announced a major expansion of its manufacturing operations in North Carolina (search), committing $771 million to create 700 new jobs across Durham and Wake counties by the end of 2030. The company broke ground on the expansion project, which represents a significant investment in the state's pharmaceutical manufacturing sector.
Expansion Details and Investment Scope
The comprehensive expansion plan combines new construction with renovation of existing facilities across three sites in the Triangle region. Novartis, which develops and manufactures innovative medicines, will enhance its pharmaceutical operations throughout Durham and Morrisville as part of this strategic investment.
Governor Josh Stein emphasized the significance of the expansion for the state's pharmaceutical industry. "North Carolina (search) continues to lead in advanced pharmaceutical manufacturing, and Novartis' expansion in the Triangle reflects our state's talent and innovative spirit," said Governor Stein.
Employment Impact and Compensation
The 700 new positions created through this expansion will offer competitive compensation packages, with an average annual salary of $111,161. This salary level significantly exceeds local averages, surpassing Durham County (search)'s average of $97,531 and Wake County (search)'s average of $76,643.
While salaries for the new positions will vary across different roles and levels, the substantial investment in human capital demonstrates Novartis' commitment to attracting top talent to support its expanded manufacturing operations in the region.
Strategic Significance for North Carolina
The Novartis expansion reinforces North Carolina (search)'s position as a hub for advanced pharmaceutical manufacturing. The Triangle region has established itself as an attractive location for pharmaceutical companies seeking to expand their manufacturing footprint, offering a combination of skilled workforce, strategic location, and supportive business environment.
The project timeline extends through 2030, indicating a long-term commitment to the region's pharmaceutical manufacturing capabilities and economic development.